Maxpro Capital Acquisition Corp.
JMAC · Nasdaq · formerly Jade Mountain Acquisition Corp.
NO ACTION REQUIRED
Nothing left to do
The purchase completed and the shares became shares in the company it bought. There is no deadline left to miss.
Cash at settlement
No cash-per-share figure was filed for this vehicle before it finished.
Last close
Daily close
No price history on file yet — daily closes accumulate from the market data feed.
Trust settled · There is no line to draw here. This vehicle has finished: the cash was paid back or spent closing the deal, so the last filed figure describes an account that no longer exists and would be a floor under nothing.
SpacBrain’s read
Trust settled
The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
In plain terms
- What it is
- A SPAC from MP One Investment, LLC, listed on Nasdaq in October 2021.
- What it's doing now
- It agreed to buy Apollomics Inc., a clinical-stage biopharmaceutical company company. That purchase completed, and it stopped being a SPAC — the shares became shares in the business it bought.
- What you should know
- This SPAC has finished. The purchase completed, and the shares became shares in the company it bought — anyone who wanted the cash instead asked for it at the vote, so there is no cash left here to claim and no deadline left to miss.
At a glance
- Where it stands
- Closed (deSPAC)
- The business it bought
- Apollomics Inc.
- Industry
- Health Care — clinical-stage biopharmaceutical company
- Deal value
- not stated in the filings we hold
- Price vs cash at settlement
- no live price on file
- Cash in trust when it settled
- not yet extracted into a snapshot — the filings below may state it
- the last trust total filed while this was still a SPAC — the account has since been paid out or used to close the deal
- IPO
- 8 October 2021
- size not on file · 101.5% of each $10 unit into trust
- Headquarters
- 5/F-4, NO. 89, TAIPEI CITY, F5, 11073
- registered in Delaware
- Lead underwriter
- not extracted from the prospectus yet
- Key officers
- Chen Yi-Kuei (Alex) (Director) · Wu Soushan (Director) · Gau Wey - Chuan (Chief Financial Officer)
- Listed securities
- JMAC common
This vehicle has finished, so there is no window to file a cash-per-share figure for and none will follow. No estimate is shown in its place.
At the 20 March 2023 event.
Nothing dated is on file. That is an absence in the record, not a statement that nothing is coming.
Yield to redemption
Nothing left to redeem — no yield to compute.
This SPAC has finished — its trust was paid back or used to close the deal, so there is nothing left to redeem and no yield to compute. A yield to redemption is a claim that you can hand these shares back for the trust cash. That account is closed, so this page will not print a number here.
What happened to the cash
The reasoning behind the verdict above, in the order the filings establish it.
- The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
What has happened, and what is coming
2 dated milestonesEvery dated step from the day it listed to the next date you may have to act on. Where you have to do something, the day your broker needs the instruction is marked too.
- 8 October 2021IPOpassed
IPO size not on file
redemption rate not stated in the filing
The deal
terms as filedWhat it is buying, on what terms, and how much of the combined company new shares take from you.
- closedHealth CareSEC primary
What Apollomics Inc. does — read from apollomicsinc.com on 26 August 2026
Apollomics Inc. is a company focused on combating pan-cancer with precision by basing clinical trials on sound mechanistic and scientific rationale. Their pipeline includes multiple targeted therapies that harness the immune system and target specific molecular pathways. The name is derived from the Greek verb 'apollymi' (to destroy) and 'omics', reflecting their mission to utilize scientific rationale to eradicate cancer.
OncologyClinical TrialsBiotechnology
Who has already taken their money back
1 filed eventEach time shareholders were offered their cash back, some took it. Heavy cash-outs drain the account and shrink the number of shares left — whatever remains has to carry the deal.
Worst single event
—
no filing states a pre-event share count
Shares redeemed, all events
10.27M
across every filed redemption event
Every figure below is stated in the linked filing; nothing here is estimated.
- Mar 20, 2023Deal voteno rate statedredeemed 10.27M sh0001410578-23-000548
The score
deterministic, from filed fieldsJMAC is not in the scored universe, so no score is shown. A withheld score is a fact about the record, not a verdict about the company.
The score is only published for names that carry both a price and a filed cash-per-share figure — 292 of the tracked fleet today. The rest keep an empty dial rather than a modelled one, and fill in by themselves as the fields land.
The company
from SEC filingsRead the full profile
Maxpro Capital Acquisition Corp. (Nasdaq: JMAC) was a blank-check company whose IPO was priced on October 8, 2021, according to a 424B prospectus. The SEC classified it under SIC industry code 6770 (Blank Checks), and its SEC CIK is 0001874259. The common ticker JMAC appears on the cover page of an 8-K filed on March 21, 2023. The company's lifecycle is closed: a Form 25 filed on March 29, 2023, under 17 CFR 240.12d2-2(a)(3) established that its Class A common stock, warrants, and units had come to evidence other securities in substitution therefor, indicating completion of a business combination, after which the vehicle no longer files.
Material findings
from the full read of every filingEvery document this company files gets read whole — body and exhibits. These are the ones the read flagged as material, newest first, each citing its filing.
Maxpro's holders exchange one-for-one into Apollomics Class A ordinary shares, while Apollomics' own holders receive Class B shares through a Share Split at an Exchange Ratio equal to 89.9 million Pre-Closing Apollomics Ordinary Shares divided by the aggregate fully-diluted Apollomics shares. The Class B carries a six-month lock-up, and the Apollomics board may in its sole discretion substitute up to 3,100,000 Class A ordinary shares for Class B in the Share Split. Maxpro Class B common stock converts one-for-one into Class A immediately before the closing.
Filings
live EDGAR feedEverything this company has filed with the SEC recently, newest first, each with a plain summary of what changed and why it matters.
- What changed vs 2022-03-31trust $105.1M → $107.3M +2%
trust account, combination deadline, going-concern doubt +31 moved · 5 with no prior record of ours
- Trust account
- $105.1M$107.3M
- Combination deadline
- 2023-04-13 · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $109Knot matched in this filing
- Mandate language
- we intend to focus on industries that complement our managem… · unchanged
- Redeemable shares
- 10.3M · unchanged
SpacBrain reads this as $2,277,072 was added to the trust between the two filings.
The clause …“expenses and other current assets — 153,986 Total Current Assets 107,337,758 752,943 Marketable securities held in Trust Account — 105,060,686 Total Assets $ 107,337,758 $ 105,813,629 ”…
The clause …“upon the earlier to occur of (i) the date on which the Company’s initial business combination is consummated and (ii) the liquidation of the Company on or before April 13, 2023 (or such later liquidation date as may be approved by”…
The clause …“The date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The”…
The clause “100,000,000 shares authorized, 490,025 shares issued and outstanding (excluding 10,350,000 shares subject to possible redemption) 49 49 Class B common stock, $ 0.0001 par value, 10,000,000 shares authorized, 2,587,500 shares issued”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
Show the other 10 filings
What changed: Maxpro Capital Acquisition Corp. issued definitive merger materials on the Business Combination Agreement dated September 14, 2022, as amended by Amendment No. 1 dated February 9, 2023, with Apollomics Inc. and Project Max SPAC Merger Sub, Inc. Merger Sub merges into Maxpro, which survives and becomes a wholly owned subsidiary of Apollomics — the SPAC becomes the subsidiary. The document is also a prospectus for up to 16,527,525 Apollomics Class A ordinary shares, 10,350,000 warrants and the 10,350,000 Class A shares issuable on their exercise. Why it matters: Maxpro's holders exchange one-for-one into Apollomics Class A ordinary shares, while Apollomics' own holders receive Class B shares through a Share Split at an Exchange Ratio equal to 89.9 million Pre-Closing Apollomics Ordinary Shares divided by the aggregate fully-diluted Apollomics shares. The Class B carries a six-month lock-up, and the Apollomics board may in its sole discretion substitute up to 3,100,000 Class A ordinary shares for Class B in the Share Split. Maxpro Class B common stock converts one-for-one into Class A immediately before the closing.
The sponsor
The people who set this company up, what they have done before, and the advisers around the deal.
MP One Investment, LLCnamed as sponsor in this SPAC’s filings — but with no researched track record behind it yet.
A missing score, not a score of zero — why
A Sponsor Score is only published once the sponsor’s prior vehicles have been verified on EDGAR and their post-close outcomes priced. That record does not exist for this sponsor yet, so no number and no tier is shown. That is a missing score, not a score of zero — and not a neutral 50 either.
Coverage so far: 301 of 1284 tracked SPACs (23%) are attached to a scored sponsor. This card fills in by itself as the research lands.
The record
The reference detail — how the shares were structured at listing, how thinly they trade, and where the company is registered.
Show the reference detail
Unit structure
Unit: U = S + W · 101.5% of the $10 unit
from 424B4 0001104659-21-124601
Trading & liquidity
Company profile
Directors & officers
- Chen Yi-Kuei (Alex)Director
- Wu SoushanDirector
- Gau Wey - ChuanChief Financial Officer
- Georges NohaDirector
- Chen Hong - Jung (Moses)Chief Executive Officer
- Yung-Fong SongChief Strategy Officer
Institutional holders
from SC 13G/13DFunds that have declared a stake above 5%. Heavy ownership by arbitrage funds usually means heavy cash-outs at the next vote.
Show the declared stakes
6 filers with a stake on file · 0 re-affirmed in the last 12 months. A stake with no amendment since is the filer’s last word on it, not proof it is still held — and percentages filed in different years are percentages of different floats, because this vehicle’s share count collapses at every redemption.
- D. E. SHAW & CO, L.P.with 1 other reporting person on the same schedule7.5% · SC 13G/AFeb 14, 2023 stale
- PERISCOPE CAPITAL INC.7.5% · SC 13G/AFeb 13, 2023 stale
- Weiss Asset Management LPwith 2 other reporting persons on the same schedule6.2% · SC 13GFeb 11, 2022 stale
- Feis Lawrence Michaelwith 1 other reporting person on the same schedule4.6% · SC 13G/ADec 8, 2021 stale
- Karpus Management, Inc.0.0% · SC 13G/AApr 11, 2023 stale
- Space Summit Capital LLCnot stated · SC 13G/AFeb 2, 2022 stale
One line per filer, not per reporting person: a joint schedule names the management company, its funds and often the individual who controls them, and all of them report the same shares. Click a name for that filer’s whole footprint across every SPAC it has declared a stake in.
News
company wires and the financial pressReporting we have matched to this ticker. Headlines belong to the outlets that wrote them.
Show the headlines
- Apollomics, Inc. Company Operational Continuity Update
GlobeNewswireOct 13, 2025
Sources on file
harvested pages, kept in fullEvery public page we have read about this company, stored in full so a source can never go missing.
Show the sources
34 full SEC filing texts archived — searchable, never lost.
- Vault note — JMAC (Maxpro Capital Acquisition Corp.)
vault-note · /vault/tickers/JMAC
- Vault deal note — Apollomics Inc. (JMAC)
vault-note · /vault/deals/apollomics-inc
- Apollomics raises $10M in private placement | APLM SEC Filing - Form 6-K
news · stocktitan.net
- Ihre Datenschutzeinstellungen
news · consent.yahoo.com
- Apollomics, Inc. Company Operational Continuity Update
news · globenewswire.com
- Home | Apollomics Inc.
company-site · apollomicsinc.com
In plain English
tap a term to open itEvery piece of jargon this page could have used, and what it actually means.
Open the plain-English guide
No floor / floorlessthe cash guarantee is gone — the price is unprotected
A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Broker action datethe day your broker needs the instruction — earlier than the official date
Brokers batch redemption instructions to the transfer agent, so the practical cutoff is roughly two business days before the published deadline. This is the date that actually costs people the floor.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Trust discountbuying below the cash held for you
Only meaningful while a redemption right exists. On a floorless name the same arithmetic is not a discount, it is the market pricing distress, and this product will not call it a yield.
Dilutionhow much of the company new shares take from you
Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.
Pro-forma equitywhat the company is valued at once the deal closes
The combined company's equity value assuming the announced terms and the redemptions that have actually happened.
ARShow much upside you get per unit of downside
SpacBrain's asymmetric-return score. It is deterministic — the same inputs always produce the same number — and it is capped, not zeroed, when the floor is gone.
De-SPACthe day the SPAC becomes the real company
The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.
Outside datethe contractual long-stop for closing the deal
A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.
Accreted NAV (estimate)the last filed cash figure, plus the interest it should have earned since
A model, not a filing: last filed value compounded at the 3-month T-bill for the days elapsed. Always shown in italic with the word estimate, and never printed beside a filed number without it.
Ask the brain
from its filingsData provenance & audit trail5 internal entries
Written by SpacBrain’s data agents whenever a figure is captured, corrected or flagged, and kept verbatim so every number on this page can be traced back to the filing that states it. This is a running log, not the current record: an early entry may be superseded by a later correction — the panels above always hold the current values.
admitted from the HISTORICAL census (EDGAR's SIC 6770 registrant list, walked in full: 3,325 registrants, 1,167 of which ever priced an IPO). The live discovery job cannot reach this registrant — it reads the filing tape, and this one stopped filing. Admission rule: src/lib/universe-admit.ts. SIC 6770 (Blank Checks); 424B 0001104659-21-124601 priced 2021-10-08; common ticker JMAC off 8-K 0001104659-23-035055 (2023-03-21); lifecycle EXITED. Ending PROVEN, not inferred: CLOSED per Form 25 0001354457-23-000227 (2023-03-29) — Form 25 filed under 17 CFR 240.12d2-2(a)(3) — the rule for securities that "have come to evidence other securities in substitution therefor", i.e. the shares became the successor's (class: Class A Common Stock, warrants, units). ipoSizeM and deadline left NULL: gross-proceeds prose conflates the over-allotment with the offering, and a charter deadline belonging to a vehicle that has ended is a date nobody can act on. ipoDate is the 424B pricing date.
sponsor "MP One Investment, LLC" sourced from prospectus definition (10-K) acc 0001410578-22-000717.
[CLOSED-2.01] SEC accession 0001104659-23-038774 (Form 8-K, item 2.01 Completion of Acquisition or Disposition of Assets); the cover's date of earliest event reported is 2023-03-29. That is the SEC's own date for this report and NOT necessarily the closing day — an 8-K may cover several events, and where the two differ the closing date is in the quoted sentence below. Target read STRUCTURALLY from the merger agreement's party list — the party that is neither the registrant (identified by the filing's own cover page) nor a merger sub (identified by the clause making it a subsidiary of another party) nor an accommodation party (identified by a "solely for purposes of" joinder), and it was the only one left. The sentence it was read from: "As previously disclosed, on September 14, 2022, Maxpro Capital Acquisition Corp., a Delaware corporation ("Maxpro"), entered into a Business Combination Agreement by and among Maxpro, Apollomics Inc., a Cayman Islands exempted company ("Apollomics"), and Project Max SPAC Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Apollomics ("Merger Sub"), which was amended by that certain First Amendment to the Business Combination Agreement ("First Amendment"), dated as of February 9, 2023 (as amended, the "Business Combination Agreement")." No deal value is set — an item-2.01 heading is not a figure. No date column is set: Deal has announcedAt, voteDate and expectedCloseAt and nowhere to record an actual close, so the SEC's date is kept here until that column exists.
entity created from the filed target name; no About paragraph on file, so every other field awaits a sourced read
OTHER -> BIOTECH, on DEFM14A 0001193125-23-054031: "Apollomics is a holding company incorporated in the Cayman Islands with its headquarters in the United States."